Five months into the Ebola outbreak in the Democratic Republic of Congo, no approved vaccine exists for the rare Bundibugyo strain, which has led to over 4,000 deaths. However, ongoing vaccine trials offer hope, according to Emanuele Capobianco of Gavi, the global vaccine alliance. Survivors and healthcare workers continue to fight on the front lines, pushing for breakthroughs in vaccine development and care to combat the ongoing crisis.

Originally reported by AllAfrica